-
-
-
-
-
-
-
Monopar Therapeutics (MNPR) PT Raised to $117 at BTIG
-
-
-
-
-
-
-
Leerink Partners on Monopar Therapeutics (MNPR): shares don't reflect 'magnitude of market opportunity'
-
-
-
-
-
-
-
Monopar Therapeutics (MNPR) Misses Q3 EPS by 48c
-
-
-
-
-
-
-
Monopar Therapeutics (MNPR) PT Raised to $105 at H.C. Wainwright
-
-
-
-
-
-
-
Oppenheimer Starts Monopar Therapeutics (MNPR) at Outperform, PT $77
-
-
-
-
-
-
-
Monopar Therapeutics (MNPR) Tops Q1 EPS by 38c
-
-
-
-
-
-
-
Monopar Therapeutics (MNPR) PT Raised to $22 at H.C. Wainwright
-
456,289 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

